vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and Bluerock Homes Trust, Inc. (BHM). Click either name above to swap in a different company.
Bluerock Homes Trust, Inc. is the larger business by last-quarter revenue ($18.9M vs $10.7M, roughly 1.8× Arbutus Biopharma Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -50.1%, a 73.6% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs 35.9%). Over the past eight quarters, Bluerock Homes Trust, Inc.'s revenue compounded faster (30.1% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.
ABUS vs BHM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $18.9M |
| Net Profit | $2.5M | $-9.5M |
| Gross Margin | — | — |
| Operating Margin | 13.9% | -48.8% |
| Net Margin | 23.5% | -50.1% |
| Revenue YoY | 522.2% | 35.9% |
| Net Profit YoY | 112.7% | -29.9% |
| EPS (diluted) | $0.01 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.9M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | $10.7M | $16.8M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | — | $12.7M | ||
| Q2 24 | — | $12.5M | ||
| Q1 24 | — | $11.2M |
| Q4 25 | — | $-9.5M | ||
| Q3 25 | — | $-10.0M | ||
| Q2 25 | $2.5M | $-5.8M | ||
| Q1 25 | — | $-7.3M | ||
| Q4 24 | — | $-7.3M | ||
| Q3 24 | — | $3.5M | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | -48.8% | ||
| Q3 25 | — | -57.6% | ||
| Q2 25 | 13.9% | -30.9% | ||
| Q1 25 | — | -42.6% | ||
| Q4 24 | — | -52.8% | ||
| Q3 24 | — | 27.9% | ||
| Q2 24 | — | -41.3% | ||
| Q1 24 | — | -28.4% |
| Q4 25 | — | -50.1% | ||
| Q3 25 | — | -60.0% | ||
| Q2 25 | 23.5% | -34.7% | ||
| Q1 25 | — | -44.7% | ||
| Q4 24 | — | -52.8% | ||
| Q3 24 | — | 27.9% | ||
| Q2 24 | — | -41.3% | ||
| Q1 24 | — | -28.4% |
| Q4 25 | — | $-0.75 | ||
| Q3 25 | — | $-0.94 | ||
| Q2 25 | $0.01 | $-0.66 | ||
| Q1 25 | — | $-0.67 | ||
| Q4 24 | — | $-0.65 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $-0.42 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $169.6M |
| Total DebtLower is stronger | $0 | $428.4M |
| Stockholders' EquityBook value | $83.0M | $128.7M |
| Total Assets | $103.3M | $1.2B |
| Debt / EquityLower = less leverage | 0.00× | 3.33× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $169.6M | ||
| Q3 25 | — | $2.1M | ||
| Q2 25 | $37.4M | $4.2M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $115.2M | ||
| Q3 24 | — | $155.1M | ||
| Q2 24 | — | $116.0M | ||
| Q1 24 | — | $92.3M |
| Q4 25 | — | $428.4M | ||
| Q3 25 | — | $415.9M | ||
| Q2 25 | $0 | $338.6M | ||
| Q1 25 | — | $336.5M | ||
| Q4 24 | — | $373.8M | ||
| Q3 24 | — | $122.5M | ||
| Q2 24 | — | $119.7M | ||
| Q1 24 | — | $120.2M |
| Q4 25 | — | $128.7M | ||
| Q3 25 | — | $131.7M | ||
| Q2 25 | $83.0M | $135.3M | ||
| Q1 25 | — | $137.1M | ||
| Q4 24 | — | $139.1M | ||
| Q3 24 | — | $142.9M | ||
| Q2 24 | — | $142.5M | ||
| Q1 24 | — | $144.5M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $222.1M | ||
| Q2 25 | $103.3M | $220.3M | ||
| Q1 25 | — | $186.2M | ||
| Q4 24 | — | $967.0M | ||
| Q3 24 | — | $800.8M | ||
| Q2 24 | — | $756.2M | ||
| Q1 24 | — | $727.4M |
| Q4 25 | — | 3.33× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | 0.00× | 2.50× | ||
| Q1 25 | — | 2.45× | ||
| Q4 24 | — | 2.69× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | 0.84× | ||
| Q1 24 | — | 0.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $27.8M |
| Free Cash FlowOCF − Capex | — | $10.4M |
| FCF MarginFCF / Revenue | — | 55.0% |
| Capex IntensityCapex / Revenue | 0.0% | 91.8% |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.8M | ||
| Q3 25 | — | $13.4M | ||
| Q2 25 | $-15.7M | $13.9M | ||
| Q1 25 | — | $951.0K | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | $10.4M | ||
| Q3 25 | — | $8.7M | ||
| Q2 25 | — | $8.8M | ||
| Q1 25 | — | $-2.9M | ||
| Q4 24 | — | $-253.0K | ||
| Q3 24 | — | $-601.0K | ||
| Q2 24 | — | $-654.0K | ||
| Q1 24 | — | $-630.0K |
| Q4 25 | — | 55.0% | ||
| Q3 25 | — | 52.4% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | -17.6% | ||
| Q4 24 | — | -1.8% | ||
| Q3 24 | — | -4.7% | ||
| Q2 24 | — | -5.2% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | — | 91.8% | ||
| Q3 25 | — | 28.5% | ||
| Q2 25 | 0.0% | 30.3% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 66.9% | ||
| Q3 24 | — | 18.0% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | 15.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
